Chronic myeloid leukaemia trials in India

1 trial · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Study of Olverembatinib (HQP1351) in Patients With CML-CP

  Where

  Bangalore, Haryāna, Hyderabad, Kolkata, New Delhi, Pune, Thiruvananthapuram

  Age

  18 years and over

  People

  333 worldwide

  Run by

  Ascentage Pharma Group Inc.

  See details and how to joinNCT06423911 · EU 2024-511495-32-00